VSVisaSignalOfficial filing intelligence

LCA activity

Crispr Therapeutics H-1B/LCA filings

Recent labor-condition rows help reveal roles, worksites, wages, and case statuses. LCA certification is not USCIS petition approval.

View PERM

Imported LCA rows

12

Median wage

$124,379

Source period

FY2026 Q2

LCA query context

How to read Crispr Therapeutics LCA results

For searches like "Crispr Therapeutics LCA", start with the official filing count, then compare role, worksite, wage, and status signals before opening individual rows.

Role signal

Principal Research Associate is the largest imported role bucket with 4 matching rows.

Worksite signal

Boston, MA is the largest imported worksite cluster with 12 matching rows.

Status signal

Certified is the largest observed case-status bucket with 12 rows.

LCA case rows with status, decision date, role, worksite, wage, and source period
CaseStatusDecisionRoleWorksiteWageSource
I-200-26083-725330CertifiedMar 31, 2026Associate Director, Regulatory AffairsBoston, MA$195,000FY2026 Q2
I-200-26014-560041CertifiedJan 22, 2026Associate Clinical Trial ManagerBoston, MA$124,919FY2026 Q2
I-200-25350-485925CertifiedDec 23, 2025Senior Medical Director, PharmacovigilanceBoston, MA$320,000FY2026 Q1
I-200-25350-485925CertifiedDec 23, 2025Senior Medical Director, PharmacovigilanceBoston, MA$320,000FY2026 Q2
I-200-25317-405485CertifiedNov 20, 2025Senior Research Associate, Translational BiologyBoston, MA$102,000FY2026 Q2
I-200-25317-405485CertifiedNov 20, 2025Senior Research Associate, Translational BiologyBoston, MA$102,000FY2026 Q1
I-200-25273-348354CertifiedNov 7, 2025Principal Research AssociateBoston, MA$123,838FY2026 Q2
I-200-25306-356554CertifiedNov 7, 2025Principal Research AssociateBoston, MA$120,000FY2026 Q2
I-200-25306-356583CertifiedNov 7, 2025Manager, Regulatory AffairsBoston, MA$127,000FY2026 Q2
I-200-25273-348354CertifiedNov 7, 2025Principal Research AssociateBoston, MA$123,838FY2026 Q1
I-200-25306-356583CertifiedNov 7, 2025Manager, Regulatory AffairsBoston, MA$127,000FY2026 Q1
I-200-25306-356554CertifiedNov 7, 2025Principal Research AssociateBoston, MA$120,000FY2026 Q1

Primary source

Where this LCA filing signal comes from

LCA rows for Crispr Therapeutics are imported from DOL OFLC LCA Disclosure Data, the official US Department of Labor disclosure dataset. See About data for source caveats and Source status for import freshness.

DOL OFLC performance page

Last verified: .

FAQ

Common questions

What does Crispr Therapeutics LCA mean on VisaSignal?

The Crispr Therapeutics LCA page summarizes imported Department of Labor labor-condition rows for this normalized employer, including roles, worksites, wages, case statuses, and source periods.

Is Crispr Therapeutics LCA activity the same as H-1B approval?

No. LCA certification is an official DOL labor-condition filing signal, but USCIS decides H-1B petitions separately. Use the page as employer research context, not as an approval record.

Is Crispr Therapeutics an H-1B sponsor?

Searches like "Crispr Therapeutics H-1B" or "Crispr Therapeutics H-1B sponsor" are best read against this LCA filing activity, which reflects historical labor-condition signals at Crispr Therapeutics. It is not a promise of future sponsorship or an indicator of any individual case outcome.

Does an LCA certification mean an H-1B petition was approved?

No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.

Does a PERM certification mean a green card was approved?

No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.

Can this data prove an employer will sponsor a candidate?

No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.

LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.